Trial Profile
Prospective Open Label Evaluation of Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy: A Pilot Study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Clobazam (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- 22 Mar 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
- 22 Mar 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2018.
- 06 Apr 2016 New trial record